NCT06660810: Neoadjuvant Intralesional Injection of Talimogene Laherparepvec
- State
- Under way
- Phase
- Phase 2
- People
- 2 taking part
- Started
- 3 Mar 2025
- Primary completion
- 26 May 2026
- Arms
- Expansion Pilot
- Results
- None posted
- 28 Oct 2024: Trial registered
- 3 Mar 2025: Trial started